Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... The most common side effects of CRINONE 8% include breast enlargement, constipation, somnolence, nausea, headache, and perineal pain. CRINONE 8% is contraindicated in ...
2009 NOV 23 ... the use of opioids is associated with gastrointestinal (GI) side effects such as constipation, abdominal pain and discomfort, bloating, gastro-oesophageal reflux and loss of ...
2009 NOV 23 ... development in the United States for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation. Under the terms of ...
2009 NOV 16 ... of once-daily dosing of the investigational drug linaclotide in patients with chronic constipation (CC). Analyses of the data indicate that in both multicenter, randomized, double-blind, ...
Subject: Forest Laboratories, Inc. and Ironwood Pharmaceuticals, Inc.
2009 NOV 16 ... and caregivers to record selected side effects (nausea, vomiting, fever, fatigue, constipation, diarrhea, tingling in the feet and hands, pain) following chemotherapy. The app uses ...
2009 NOV 16 ... Madrid, Spain, "The objective of this study was to establish screening criteria for constipation in palliative care and, subsequently, to determine data for diagnostic suspicion of ...
2009 NOV 16 ... "STW 5 may be a novel option to treat secretory disorders associated with IBS and constipation." Krueger and colleagues published their study in Neurogastroenterology ...
2009 NOV 24 ... during bowel movements, sitting on the toilet for an extended time, chronic diarrhea or constipation, obesity, lifting heavy objects, sitting or standing for long periods and pregnancy. ...
2009 NOV 16 ... ≥ 2 percent) in CINV trials with palonosetron were headache (9 percent) and constipation (5 percent), and they were similar to the comparators. In PONV trials, the most commonly ...
2009 NOV 23 ... is available in Japan and Korea to treat intestinal disorders such as diarrhea and constipation. The bacterium is quite hardy and can survive the hostile environment of the stomach and ...
2009 NOV 16 ... cancer was anal sex. Also considered risks were ''bad food,'' digestion leading to constipation, and strained bowel movements. Screening barriers included stigma, misperceptions, ...
2009 NOV 23 ... controlled hypertension and diabetes mellitus presented with left iliac fossa pain, constipation alternating with diarrhea, and weight loss. She had been diagnosed with idiopathic ...
2009 NOV 16 ... the efficacy and safety of rifaximin 550 mg TID in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS). In each trial rifaximin versus placebo treated ...
2009 NOV 23 ... the efficacy and safety of rifaximin 550mg tablets in the treatment of patients with non-constipation irritable bowel syndrome (IBS). In each trial, rifaximin-treated patients demonstrated a ...
2009 NOV 16 ... significant. The most commonly reported adverse events related to palonosetron were constipation and headache, confirming the class safety profile," wrote Y. Segawa and colleagues, ...
2009 NOV 16 ... away. The most common side effects include nausea (30%), sleep problems, constipation, gas, and/or vomiting. Side effects that are bothersome or don't go away should be ...
2009 NOV 23 ... Sucampo markets AMITIZA® (lubiprostone) 24 mcg in the U.S. for chronic idiopathic constipation in adults and Amitiza 8 mcg in the U.S. to treat irritable bowel syndrome with...
2009 NOV 16 ... of 2008 from the initial stocking of Amitiza (8 mcg) for irritable bowel syndrome with constipation (IBS-C). Net sales of Amitiza, as reported by our collaboration partner ...
